Blackburn James, Tarttelin Emma E, Gregory-Evans Cheryl Y, Moosajee Mariya, Gregory-Evans Kevin
Department of Cell and Molecular Biology, Faculty of Medicine, Imperial College London, London, United Kingdom.
Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4613-21. doi: 10.1167/iovs.03-0112.
To determine the important transcriptional control elements and sites of expression of fibulin-3 in mammalian retina.
Sequencing and 5' rapid amplification of cDNA ends (RACE) were undertaken to characterize the genomic sequence upstream of the FBLN3 coding sequence. Reporter deletion-mutation constructs were used in luciferase transfection assays to determine the important regulatory motifs. Fibulin-3 expression in mouse and human retina was studied by in situ hybridization and RT-PCR. The effect of 17beta-estradiol on fibulin-3 production was studied in COS-7 and ARPE-19 cells.
Two untranslated exons were fully sequenced completing the characterization of FBLN3 that comprises 12 exons. Reporter assays suggest that the FBLN3 proximal promoter is contained within 425 bp upstream of exon 1. Important regulatory elements include three Sp1-binding sites, a Tant motif (trans-activating) and an estrogen response element (ERE) binding site (trans-repressing). No TATA or CAAT regulatory boxes were identified. RT-PCR suggests that the fibulin-3 gene is expressed in murine and human RPE, and in situ studies confirm that Fbln3 is expressed in the outer and inner nuclear layers, but strikingly not in the ganglion cell layer. Fibulin-3 expression in ARPE-19 cells could be modified by varying the amount of estrogen in the cell culture medium.
The 5' end of the FBLN3 gene has been characterized, and the important upstream motifs regulating its transcription have been identified. Fibulin-3 is expressed in adult retina and at early stages in human and mouse development. Estrogen may be an important regulator of fibulin-3 expression, and this highlights a novel mechanism by which circulating estrogen may control the composition of the retinal extracellular matrix.
确定纤连蛋白-3在哺乳动物视网膜中的重要转录控制元件及表达位点。
进行测序及5' cDNA末端快速扩增(RACE)以鉴定FBLN3编码序列上游的基因组序列。利用报告基因缺失突变构建体进行荧光素酶转染试验,以确定重要的调控基序。通过原位杂交和RT-PCR研究纤连蛋白-3在小鼠和人类视网膜中的表达。在COS-7和ARPE-19细胞中研究17β-雌二醇对纤连蛋白-3产生的影响。
对两个非翻译外显子进行了全序列测定,完成了包含12个外显子的FBLN3的鉴定。报告基因试验表明,FBLN3近端启动子位于外显子1上游425 bp内。重要的调控元件包括三个Sp1结合位点、一个Tant基序(反式激活)和一个雌激素反应元件(ERE)结合位点(反式抑制)。未鉴定到TATA或CAAT调控框。RT-PCR表明纤连蛋白-3基因在小鼠和人类视网膜色素上皮(RPE)中表达,原位研究证实Fbln3在外核层和内核层表达,但在神经节细胞层中明显不表达。通过改变细胞培养基中雌激素的量,可以改变ARPE-19细胞中纤连蛋白-3的表达。
已鉴定出FBLN3基因的5'端,并确定了调控其转录的重要上游基序。纤连蛋白-3在成人视网膜以及人类和小鼠发育的早期阶段表达。雌激素可能是纤连蛋白-3表达的重要调节因子,这突出了循环雌激素可能控制视网膜细胞外基质组成的新机制。